THERAPEUTIC EQUIVALENCE OF ORIGINAL CLOPIDOGREL (PLAVIX) AND ITS GENERIC (EGITROMB). RESULTS OF COMPARATIVE RANDOMIZED CROSS-OVER BLIND STUDY

<p>Aim. To study therapeutic equivalence (efficacy, safety and tolerability) of original clopidogrel (Plavix) and its generic (Egitromb) in patients of high cardiovascular risk. Material and methods. Thirty one patients with coronary heart disease and indications for clopidogrel therapy were involve...

Cijeli opis

Bibliografski detalji

Glavni autori:	V. V. Yakusevich, A. S. Petrochenko, V. A. Simonov, N. Yu. Levshin, A. D. Deev
Format:	Artigo
Jezik:	Inglês
Izdano:	Столичная издательская компания 2016-01-01
Serija:	Рациональная фармакотерапия в кардиологии
Teme:	клопидогрел агрегация тромбоцитов оригинальный препарат дженерик
Online pristup:	http://www.rpcardio.ru/jour/article/view/678
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!